Greater Midwest Financial Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-47,052
Closed -$1.36M 62
2024
Q2
$1.36M Buy
47,052
+3,403
+8% +$93.7K 0.86% 25
2024
Q1
$1.21M Buy
43,649
+3,903
+10% +$108K 0.76% 27
2023
Q4
$1.14M Buy
+39,746
New +$1.2M 0.78% 27

Other funds holding PFE

Greater Midwest Financial Group's PFE Position: Q3 2024 in Review

Greater Midwest Financial Group sold out of Pfizer (PFE) in Q3 2024, closing a stake of 47,052 shares — an estimated $1.36M sold.

Greater Midwest Financial Group first reported a position in PFE in Q4 2023 and held it in 3 quarters. The position peaked at $1.36M in Q2 2024. 2,909 funds tracked by Wall St. Rank hold PFE as of Q3 2024.

  • Greater Midwest Financial Group reported no remaining Pfizer position as of Q3 2024 after selling out during the quarter.
  • Greater Midwest Financial Group sold 47,052 Pfizer shares in Q3 2024, an estimated $1.36M.
  • Greater Midwest Financial Group first reported a position in Pfizer in Q4 2023 and held it in 3 quarters.
  • Greater Midwest Financial Group's Pfizer position peaked at $1.36M in Q2 2024.
  • 2,909 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.

Based on Greater Midwest Financial Group's 13F filing for Q3 2024, filed 16 Oct 2024.